Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female participants who agree to contraception requirements
Have a body mass index (BMI) within the range of 27 to 40 kg/m², inclusive
Have had a stable weight for the 3 months
You may not be if
Have a history of significant atopy (severe allergic manifestations), multiple or severe drug allergies, or severe posttreatment hypersensitivity reactions
Have a history or presence of psychiatric disorders, including a history of major depressive disorder or severe psychiatric disorders such as schizophrenia, bipolar disorder within the last 3 years
Have been diagnosed with Type 1 or Type 2 Diabetes Mellitus
Have a history of chronic medical conditions involving the heart, liver, or kidneys
Have a history of any malignancy within the past 5 years
Have a history or presence of a GI disorder
Have had within the last 6 months, or plan to have during the study, a device-based or surgical treatment use for obesity
Have been treated, or plan to be treated, with prescription medications or other non-approved drugs intended to promote weight loss, within 3 months prior to screening
For participants in Part B, have previously received tirzepatide within 6 months prior to screening
For participants in Part B, have a personal or family history of medullary thyroid carcinoma, or have multiple endocrine neoplasia syndrome type 2
